Literature DB >> 28195874

An effectiveness study of group psychoeducation for hepatitis C patients in community clinics.

Carol S North1, David E Pollio, Omar T Sims, Mamta K Jain, Geri R Brown, Dana L Downs, Mauricio Lisker-Melman, Barry A Hong.   

Abstract

OBJECTIVE: A successful psychoeducation program for serious mental illness, PsychoEducation Responsive to Families (PERF), was modified for hepatitis C virus (HCV). An effectiveness study was carried out comparing HCV-PERF with didactic education. PATIENTS AND METHODS: A sample of 309 adult HCV patients was recruited from three outpatient settings and randomized (60% HCV-PERF, 40% didactic control). Groups met for 90 min bimonthly for 6 months following separate structured protocols. HCV-PERF sessions included a didactic curriculum developed uniquely for groups by member choice, with group problem-solving and support interactions. Patients were assessed at baseline, after the intervention, and 1 year later. Demographic and HCV-related variables and structured diagnostic interview data were obtained.
RESULTS: Both groups improved significantly on major depression and alcohol and drug use, quality of life, risk behaviors, and treatment satisfaction, and worsened on disability and perceived HCV-related problems. Intervention groups did not differ on outcomes.
CONCLUSION: Even though the active intervention did not achieve a significant improvement relative to the control condition, the observable improvements in both conditions warrant further exploration of the contributions of education and support as potentially important elements of HCV behavioral intervention. Further study is needed to identify elements common to education interventions that may be contributory to the improved outcomes over time.

Entities:  

Mesh:

Year:  2017        PMID: 28195874      PMCID: PMC5404973          DOI: 10.1097/MEG.0000000000000860

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  12 in total

1.  Demand for and use of advocacy services for persons living with HIV/AIDS. Four Special Projects of National Significance HIV Advocacy Projects.

Authors:  R Hines; C L Decker; W P Witt; K Marconi; B Singer
Journal:  AIDS Public Policy J       Date:  1997

Review 2.  Hepatitis C virus infection in USA: an estimate of true prevalence.

Authors:  Eric Chak; Andrew H Talal; Kenneth E Sherman; Eugene R Schiff; Sammy Saab
Journal:  Liver Int       Date:  2011-03-16       Impact factor: 5.828

Review 3.  Treatment of hepatitis C: a systematic review.

Authors:  Anita Kohli; Ashton Shaffer; Amy Sherman; Shyam Kottilil
Journal:  JAMA       Date:  2014-08-13       Impact factor: 56.272

4.  The family as caregiver: a group psychoeducation model for schizophrenia.

Authors:  C S North; D E Pollio; B Sachar; B Hong; K Isenberg; G Bufe
Journal:  Am J Orthopsychiatry       Date:  1998-01

Review 5.  The role of hepatitis C support groups.

Authors:  Maureen Cormier
Journal:  Gastroenterol Nurs       Date:  2005 May-Jun       Impact factor: 0.978

6.  Estimating progression to cirrhosis in chronic hepatitis C virus infection.

Authors:  A J Freeman; G J Dore; M G Law; M Thorpe; J Von Overbeck; A R Lloyd; G Marinos; J M Kaldor
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

7.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

Authors:  R C Kessler; K A McGonagle; S Zhao; C B Nelson; M Hughes; S Eshleman; H U Wittchen; K S Kendler
Journal:  Arch Gen Psychiatry       Date:  1994-01

Review 8.  Hepatitis C treatment and SVR: the gap between clinical trials and real-world treatment aspirations.

Authors:  Carol S North; Barry A Hong; Sunday A Adewuyi; David E Pollio; Mamta K Jain; Robert Devereaux; Nana A Quartey; Sarah Ashitey; William M Lee; Mauricio Lisker-Melman
Journal:  Gen Hosp Psychiatry       Date:  2012-12-06       Impact factor: 3.238

9.  Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.

Authors:  Gary L Davis; Miriam J Alter; Hashem El-Serag; Thierry Poynard; Linda W Jennings
Journal:  Gastroenterology       Date:  2009-10-25       Impact factor: 22.682

10.  The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

Authors:  C A McHorney; J E Ware; A E Raczek
Journal:  Med Care       Date:  1993-03       Impact factor: 2.983

View more
  2 in total

1.  Prospective Longitudinal Substance Use Patterns in Patients Preparing for Hepatitis C Treatment.

Authors:  Carol S North; David E Pollio; Omar T Sims; Mamta K Jain; Barry A Hong
Journal:  J Dual Diagn       Date:  2018-01-18

2.  A Systematic Comparison of African American and Non-African American Patients on Psychosocial Aspects of Hepatitis C Infection.

Authors:  Omar T Sims; Barry A Hong; Shaonin Ji; David E Pollio; Carol S North
Journal:  J Relig Health       Date:  2018-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.